• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Elite Pharms Inc (OP:ELTP)

    0.2970 +0.0020 (+0.68%)
    Streaming Delayed Price Updated: 11:14 AM EDT, Aug 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Elite Pharms Inc

    < Previous 1 2 3 Next >
    News headline image
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022
    Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year Ended September 30, 2021 and Provides Conference Call Information
    Conference Call Scheduled for Tuesday, November 16th at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 15, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2022 Financial Results on November 16, 2021
    Financials for Second Quarter Fiscal Year 2022 Ended September 30, 2021 will be released November 15, 2021 NORTHVALE, NJ / ACCESSWIRE / November 9, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022 Ended June 30, 2021 and Provides Conference Call Information
    Conference Call Scheduled for Tuesday, August 17 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 16, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company”) (OTCQB:ELTP), a specialty... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2022 Financial Results on August 17, 2021
    Financials for First Quarter Fiscal Year 2022 Ended June 30, 2021 will be released August 16, 2021 NORTHVALE, NJ / ACCESSWIRE / August 10, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information
    Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021
    Financials for Fiscal Year Ended March 31, 2021 will be released June 14, 2021 NORTHVALE, NJ / ACCESSWIRE / June 8, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules
    NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    News headline image
    Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer
    NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic... 
    From Elite Pharmaceuticals, Inc.
    Via AccessWire
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.